Matinas BioPharma Holdings, Inc. (MTNB)

MTNB Revenue

In the year 2023, Matinas BioPharma Holdings had annual revenue of $1.10M, a decrease of -65.62%.

• Revenue (ttm): $1.10M
• Revenue Growth: -65.62%
• P/S Ratio: 42.50
• Revenue / Employee: $34,250
• Employees: 32
• Market Cap: 46.58M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.10M	-2.09M	-65.62%
Dec 31, 2022	3.19M	3.16M	9,560.61%
Dec 31, 2021	33.00K	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.